Goldman Sachs Group Inc Theravance Biopharma, Inc. Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 333,551 shares of TBPH stock, worth $2.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
333,551
Previous 222,750 49.74%
Holding current value
$2.7 Million
Previous $2 Million 41.54%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$8.29 - $9.92 $918,540 - $1.1 Million
110,801 Added 49.74%
333,551 $2.83 Million
Q1 2024

May 15, 2024
SELL
$8.22 - $11.59 $522,307 - $736,440
-63,541 Reduced 22.19%
222,750 $2 Million
Q4 2023

Feb 13, 2024
BUY
$8.58 - $11.4 $141,621 - $188,168
16,506 Added 6.12%
286,291 $3.22 Million
Q3 2023

May 14, 2024
SELL
$8.38 - $10.44 $138,320 - $172,322
-16,506 Reduced 5.77%
269,785 $2.33 Million
Q3 2023

Nov 14, 2023
SELL
$8.38 - $10.44 $593,421 - $739,298
-70,814 Reduced 20.79%
269,785 $2.33 Million
Q2 2023

May 14, 2024
BUY
$10.16 - $11.92 $42,387 - $49,730
4,172 Added 1.24%
340,599 $3.53 Million
Q2 2023

Aug 14, 2023
BUY
$10.16 - $11.92 $42,387 - $49,730
4,172 Added 1.24%
340,599 $3.53 Million
Q1 2023

May 14, 2024
SELL
$9.87 - $11.44 $94,317 - $109,320
-9,556 Reduced 2.76%
336,427 $3.65 Million
Q1 2023

May 11, 2023
SELL
$9.87 - $11.44 $94,317 - $109,320
-9,556 Reduced 2.76%
336,427 $3.65 Million
Q4 2022

May 14, 2024
SELL
$9.65 - $11.34 $2.67 Million - $3.14 Million
-276,876 Reduced 44.45%
345,983 $3.88 Million
Q4 2022

Feb 13, 2023
SELL
$9.65 - $11.34 $2.67 Million - $3.14 Million
-276,876 Reduced 44.45%
345,983 $3.88 Million
Q3 2022

May 14, 2024
BUY
$8.39 - $10.22 $334,173 - $407,062
39,830 Added 6.83%
622,859 $6.32 Million
Q3 2022

Nov 10, 2022
BUY
$8.39 - $10.22 $334,173 - $407,062
39,830 Added 6.83%
622,859 $6.32 Million
Q2 2022

May 14, 2024
BUY
$8.41 - $10.34 $2.5 Million - $3.07 Million
296,738 Added 103.65%
583,029 $5.28 Million
Q2 2022

Aug 15, 2022
SELL
$8.41 - $10.34 $3.31 Million - $4.07 Million
-393,344 Reduced 40.29%
583,029 $5.28 Million
Q1 2022

May 16, 2022
BUY
$8.33 - $12.96 $5.27 Million - $8.2 Million
632,582 Added 184.0%
976,373 $9.34 Million
Q4 2021

Feb 14, 2022
BUY
$7.42 - $11.05 $293,342 - $436,850
39,534 Added 12.99%
343,791 $3.8 Million
Q3 2021

Nov 10, 2021
BUY
$6.77 - $14.41 $2.06 Million - $4.38 Million
304,257 New
304,257 $2.25 Million

Others Institutions Holding TBPH

# of Institutions
134
Shares Held
48.7M
Call Options Held
13.9K
Put Options Held
3.1K
View Full List

About Theravance Biopharma, Inc.

TBPH Quotes by TradingView
  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $541M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email